SEC Form 4 · accession 0001479791-18-000020
INVO Bioscience, Inc. · IVOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Claude Ranoux
10% Owner
Period of report
Dec 3, 2018
Accepted (ET)
Dec 3, 2018 · 12:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001417926
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| INVO Bioscience common stock | Dec 3, 2018 | I | 1,000,000 | $0.0001 | D | 25,194,000 | D | |
| INVO Bioscience common stock | Dec 3, 2018 | S | 500,000 | $0.05 | D | 24,694,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
The 1,000,000 shares were disposed to spouse pursuant to a divorce decree. The 500,000 shares were issued following an old convertible note with a conversion of 5 cents a share.